CClinicalTrials.gg
CompletedNCT05689073Updated Jan 19, 2024

A Conversational AI System to Enhance Knowledge About Vaccines and Promote Vaccination

An interventional study of Conversational AI system and Printed educational Brochure in Vaccination Hesitancy, sponsored by Sun Yat-sen University. Completed at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-19.

Sponsored by Sun Yat-sen University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
430
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is designed to contribute to the growing body of evidence on the efficacy of digital health interventions. By rigorously evaluating the impact of the AI system on vaccine knowledge and acceptance, the study aims to inform future health communication strategies and policies. It stands as a potential model for integrating AI into public health initiatives, showcasing how technology can be harnessed to improve health outcomes on a large scale.

02

Conditions studied

  • Vaccination Hesitancy
03

In context

Lead sponsor

Sun Yat-sen University is the lead sponsor of 1,644 studies on the registry; 602 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Individuals aged 18 or above
  • Owning a smartphone/tablet capable of using the study app
  • Willing to provide informed consent.

Exclusion criteria

Exclusion Criteria

  • Individuals with ocular or hearing disorders that preclude the use of mobile phones or reading.
  • Individuals with mental disorders that preclude the use of mobile phones or reading.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
430 participants (actual)

Study arms

  • Experimental
    Conversational AI system

    Device: Conversational AI system

  • Active comparator
    Educational brochure

    Other: Printed educational Brochure

Interventions

  • DeviceConversational AI system

    The conversational AI system based on LLM processes user queries with a sophisticated generation, decision, action, and safety framework to provide optimal feedback. The system has several key features. Firstly, it utilizes retrieval-augmented in-context learning to enhance responses generated by the LLM, sourcing information from trustworthy websites. Secondly, it includes Guardrail module that addresses potential harmful content in the LLM-generated responses by clarifying and validating the content before delivery. Furthermore, the AI system is equipped with Self-checking memory module that retains essential clinical characteristics across multi-turn dialogues, ensuring the continuity and consistency of its interactions with users. The educational content about vaccination was derived from the official website of World Health Organization (https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-what-is-vaccination).

  • OtherPrinted educational Brochure

    A printed brochure whose content about vaccination was derived from the official website of World Health Organization (https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-what-is-vaccination).

06

What researchers measure

Primary outcomes

  1. Acceptance of vaccines

    Vaccine acceptance was evaluated based on responses to the question, 'Based on your actual situation, please choose the extent of your willingness to get vaccinated.' The response options were: Absolutely refuse, Refuse but uncertain about the future, Have not considered it yet, Accept but still considering, and Completely willing. Vaccine acceptance was considered if the participant selected 'Completely willing.

    Time frame: Day 14

Secondary outcomes

  1. Hesitancy of vaccination

    The Vaccine Hesitancy Scale was developed based on the "3Cs" model (confidence, complacency, and convenience) by the SAGE Working Group on Vaccine Hesitancy, encompassing three aspects: confidence, complacency, and convenience. It utilizes a Likert 5-point scale (Strongly Disagree, Disagree, Neutral, Agree, Strongly Agree) for scoring. For the complacency dimension, aspect, scoring is reversed with "Strongly Agree" to "Strongly Disagree" rated as 5 to 1 points, respectively. In contrast, other items follow the standard scoring, where "Strongly Agree" to "Strongly Disagree" are scored from 1 to 5 points. Confidence is measured by perceived vaccine safety and efficacy. Complacency is assessed through perceived necessity of the vaccine and the severity of the preventable diseases. Convenience is evaluated by the perceived ease of transportation and appointment scheduling.

    Time frame: Day 14

Other outcomes

  1. Feelings of coercion

    To assess feelings of coercion related to vaccination, participants were asked a single question: 'When deciding whether to receive the vaccines, do you feel forced to either take or not take the vaccine?' This question utilizes a 5-point Likert scale (very low, low, neutral, high, very high) with lower scores indicating lower feelings of perceived coercion.

    Time frame: Day 14

07

Study locations

1 site
  • Zhongshan Ophthalmic Center
    Guangzhou, Guangdong 510000, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05689073
Lead sponsor
Sun Yat-sen University
Responsible party
Yingfeng Zheng (Professor, Sun Yat-sen University) — Principal investigator
First posted
Jan 18, 2023
Start date
May 1, 2023
Primary completion
Aug 31, 2023
Completion
Aug 31, 2023
Last update
Jan 19, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion